Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations

Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Sim...

Full description

Bibliographic Details
Main Authors: Rodney Shackelford, Maressa Pollen, Moise Vora, Tamara T. Jusion, James Cotelingam, Binu Nair
Format: Article
Language:English
Published: Karger Publishers 2014-05-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/362788
_version_ 1811224909028786176
author Rodney Shackelford
Maressa Pollen
Moise Vora
Tamara T. Jusion
James Cotelingam
Binu Nair
author_facet Rodney Shackelford
Maressa Pollen
Moise Vora
Tamara T. Jusion
James Cotelingam
Binu Nair
author_sort Rodney Shackelford
collection DOAJ
description Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Simultaneous BRAF V600E and NRAS Q61A mutations in melanoma are rare, with evidence suggesting that up to 2.9% (2/69) of primary cutaneous melanomas carry both mutations. Here we describe a 42-year-old man with concurrent BRAF E586K and NRAS Q81K driver mutations. To our knowledge, this is the first description of these driver mutations occurring simultaneously in primary cutaneous melanoma.
first_indexed 2024-04-12T08:56:50Z
format Article
id doaj.art-23bebe7d63854a2d8478a89ee110c116
institution Directory Open Access Journal
issn 1662-6575
language English
last_indexed 2024-04-12T08:56:50Z
publishDate 2014-05-01
publisher Karger Publishers
record_format Article
series Case Reports in Oncology
spelling doaj.art-23bebe7d63854a2d8478a89ee110c1162022-12-22T03:39:21ZengKarger PublishersCase Reports in Oncology1662-65752014-05-017229730010.1159/000362788362788Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K MutationsRodney ShackelfordMaressa PollenMoise VoraTamara T. JusionJames CotelingamBinu NairCutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Simultaneous BRAF V600E and NRAS Q61A mutations in melanoma are rare, with evidence suggesting that up to 2.9% (2/69) of primary cutaneous melanomas carry both mutations. Here we describe a 42-year-old man with concurrent BRAF E586K and NRAS Q81K driver mutations. To our knowledge, this is the first description of these driver mutations occurring simultaneously in primary cutaneous melanoma.http://www.karger.com/Article/FullText/362788Cutaneous melanomaConcurrent BRAF E586K and NRAS Q81K mutationsSkin cancer
spellingShingle Rodney Shackelford
Maressa Pollen
Moise Vora
Tamara T. Jusion
James Cotelingam
Binu Nair
Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
Case Reports in Oncology
Cutaneous melanoma
Concurrent BRAF E586K and NRAS Q81K mutations
Skin cancer
title Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
title_full Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
title_fullStr Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
title_full_unstemmed Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
title_short Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
title_sort malignant melanoma with concurrent braf e586k and nras q81k mutations
topic Cutaneous melanoma
Concurrent BRAF E586K and NRAS Q81K mutations
Skin cancer
url http://www.karger.com/Article/FullText/362788
work_keys_str_mv AT rodneyshackelford malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations
AT maressapollen malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations
AT moisevora malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations
AT tamaratjusion malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations
AT jamescotelingam malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations
AT binunair malignantmelanomawithconcurrentbrafe586kandnrasq81kmutations